Financhill
Sell
37

ARCB Quote, Financials, Valuation and Earnings

Last price:
$68.34
Seasonality move :
7.52%
Day range:
$67.39 - $69.07
52-week range:
$55.19 - $129.83
Dividend yield:
0.7%
P/E ratio:
9.02x
P/S ratio:
0.39x
P/B ratio:
1.21x
Volume:
265.4K
Avg. volume:
341.2K
1-year change:
-35.5%
Market cap:
$1.6B
Revenue:
$4.2B
EPS (TTM):
$7.56

Earnings Data

Next earnings date for ARCB
Aug 01
2025
Most recent earnings per share
$0.13
Missed by $0.39
(Apr 29/2025)
Consensus Estimate
$0.52
(Apr 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARCB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/01/2025 Q2 $1B -- -- $1.39 --
04/29/2025 Q1 $986.1M $967.1M $0.13 $0.52 -$0.39
01/31/2025 Q4 $995M $1B $1.24 $1.05 $0.19
11/01/2024 Q3 $1.1B $1.1B $4.23 $1.85 $2.38
08/02/2024 Q2 $1.1B $1.1B $1.96 $2.06 -$0.10
04/30/2024 Q1 $1B $1B -$0.10 $1.53 -$1.63
02/06/2024 Q4 $1.1B $1.1B $2.01 $2.23 -$0.22
10/27/2023 Q3 $1.1B $1.1B $1.42 $1.50 -$0.08
07/28/2023 Q2 $1.1B $1.1B $1.64 $2.02 -$0.38
04/28/2023 Q1 -- $1.1B $2.84 -- --
02/03/2023 Q4 -- $1.2B $1.48 -- --
11/01/2022 Q3 -- $1.3B $3.50 -- --
07/29/2022 Q2 -- $1.3B $4.00 -- --
04/29/2022 Q1 -- $1.3B $2.68 -- --
02/01/2022 Q4 -- $971.3M $2.47 -- --
11/02/2021 Q3 -- $1B $2.38 -- --
08/02/2021 Q2 -- $949M $2.27 -- --
05/04/2021 Q1 -- $829.2M $0.87 -- --
02/02/2021 Q4 -- $816.4M $0.89 -- --
11/03/2020 Q3 -- $795M $1.11 -- --
07/29/2020 Q2 -- $627.4M $0.61 -- --
05/05/2020 Q1 -- $701.4M $0.07 -- --
01/30/2020 Q4 -- $717.4M -$0.22 -- --
10/31/2019 Q3 -- $787.6M $0.62 -- --
07/30/2019 Q2 -- $771.5M $0.92 -- --
05/02/2019 Q1 -- $711.8M $0.18 -- --
01/30/2019 Q4 -- $774.3M $0.57 -- --
11/01/2018 Q3 -- $826.2M $1.52 -- --
07/31/2018 Q2 -- $793.4M $0.05 -- --
05/10/2018 Q1 -- $700M $0.37 -- --
01/31/2018 Q4 -- $710.7M $1.37 -- --
11/03/2017 Q3 -- $744.3M $0.56 -- --
07/28/2017 Q2 -- $720.4M $0.60 -- --
05/04/2017 Q1 -- $651.1M -$0.29 -- --
02/08/2017 Q4 -- $688.2M $0.06 -- --
11/03/2016 Q3 -- $713.9M $0.49 -- --
07/29/2016 Q2 -- $676.6M $0.39 -- --
04/29/2016 Q1 -- $621.5M -$0.24 -- --
02/03/2016 Q4 -- $648.1M $0.19 -- --
10/30/2015 Q3 -- $709.4M $0.72 -- --
08/03/2015 Q2 -- $696.1M $0.74 -- --

ArcBest Earnings Questions

  • How Much did ArcBest Generate in Revenue Last Quarter?

    ArcBest reported $967.1M worth of top line sales in its most recent quarter.

  • Did ArcBest Beat Earnings Last Quarter?

    ArcBest announced earnings per share of $0.13 which represents a miss of analyst forecast a $0.52 per share.

  • Is ArcBest Profitable?

    ArcBest reported $55.5M that represents $2.39 per share over the last quarter.

  • What is the Analyst Consensus for ArcBest EPS Next Year?

    ArcBest's earnings are forecast to decrease from $7.30 per share to $6.01 per share next year representing a decrease of -33.74%.

  • When is ArcBest's Earnings Date?

    ArcBest's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will OXY Stock Go Now?
How High Will OXY Stock Go Now?

Occidental Petroleum (NYSE:OXY), a stock that has been made famous…

Is Stellantis a Good Dividend Stock to Buy Right Now?
Is Stellantis a Good Dividend Stock to Buy Right Now?

Stellantis (NYSE: STLA) isn’t the first name most income investors think of,…

Where Will Brookfield Asset Management Stock Be In 1 Year?
Where Will Brookfield Asset Management Stock Be In 1 Year?

On a trailing basis Brookfield earned $1.60 per share over…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
83
ARQQ alert for Jun 20

Arqit Quantum [ARQQ] is up 15.46% over the past day.

Sell
47
RGC alert for Jun 20

Regencell Bioscience Holdings [RGC] is down 43.96% over the past day.

Sell
49
QNTM alert for Jun 20

Quantum BioPharma [QNTM] is up 23.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock